Webinar | Why 95% of AI Projects Stall – and How Agentic AI Changes the Game
Our perspective on AL/ML in the life sciences industry.
If your company is experimenting with AI, here’s a statistic worth pausing on. Recent MIT research says “95% of AI initiatives fail to show real
The pharmaceutical industry has cracked some of its toughest challenges, from shortening trial timelines to improving patient recruitment and building sophisticated data platforms. Yet one
When racing to develop a COVID-19 vaccine, a top 20 pharmaceutical company partnered with Saama to tackle one of the most critical milestones in clinical
ADaM package generation has long been one of the most persistent bottlenecks in clinical development, often consuming over two months across specification creation, programming, and
Across the life sciences industry, conversations around AI validation tend to follow a familiar path. A team introduces an AI system that demonstrates 95% accuracy.
Clinical development has never been more advanced. We can stream biomarker data in real-time, interpret complex protocols using generative Artificial Intelligence (AI), and transform clinical
The ACDM AI/ML Conference, held from June 23- 24 2025 in Frankfurt, Germany, offered a reality check on where the life sciences industry truly stands
Life sciences companies today are dealing with more data than ever before. Beyond the traditional sources we’ve worked with for years, we now have real-world
Clinical trials are experiencing a major transformation. While the core goal remains bringing safe, effective treatments to patients, how we reach that goal is changing
